LTFS
ABBV icon

Ladenburg Thalmann Financial Services’s AbbVie ABBV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$30.9M Buy
360,025
+24,193
+7% +$2.01M 0.19% 117
2019
Q3 		$25.4M Buy
335,832
+6,147
+2% +$421K 0.18% 128
2019
Q2 		$24M Sell
329,685
-571
-0.2% -$44.9K 0.17% 130
2019
Q1 		$26.6M Buy
330,256
+18,594
+6% +$1.52M 0.2% 116
2018
Q4 		$28.7M Buy
311,662
+19,161
+7% +$1.69M 0.26% 92
2018
Q3 		$27.7M Buy
292,501
+10,431
+4% +$989K 0.23% 104
2018
Q2 		$26.7M Hold
282,070
– – 0.25% 95
2018
Q1 		$26.7M Buy
282,070
+11,429
+4% +$1.26M 0.25% 95
2017
Q4 		$26.2M Buy
270,641
+29,658
+12% +$2.8M 0.25% 91
2017
Q3 		$21.4M Sell
240,983
-2,765
-1% -$210K 0.23% 103
2017
Q2 		$17.7M Buy
243,748
+10,118
+4% +$680K 0.21% 111
2017
Q1 		$15.2M Buy
233,630
+30,632
+15% +$1.93M 0.19% 120
2016
Q4 		$12.7M Sell
202,998
-12,278
-6% -$749K 0.18% 126
2016
Q3 		$13.6M Buy
215,276
+3,411
+2% +$221K 0.2% 115
2016
Q2 		$13.1M Buy
211,865
+13,301
+7% +$810K 0.21% 107
2016
Q1 		$11.3M Buy
198,564
+77,772
+64% +$4.33M 0.2% 115
2015
Q4 		$7.15M Buy
120,792
+3,237
+3% +$186K 0.13% 156
2015
Q3 		$6.36M Sell
117,555
-4,234
-3% -$276K 0.13% 161
2015
Q2 		$8.19M Buy
121,789
+6,678
+6% +$436K 0.15% 149
2015
Q1 		$6.74M Buy
115,111
+15,671
+16% +$947K 0.13% 169
2014
Q4 		$6.49M Buy
99,440
+12,830
+15% +$809K 0.14% 151
2014
Q3 		$5M Buy
86,610
+1,165
+1% +$64.7K 0.14% 144
2014
Q2 		$4.82M Buy
85,445
+1,163
+1% +$61K 0.13% 141
2014
Q1 		$4.33M Buy
84,282
+659
+0.8% +$33.3K 0.13% 128
2013
Q4 		$4.41M Sell
83,623
-516
-0.6% -$25.4K 0.14% 131
2013
Q3 		$3.77M Buy
84,139
+906
+1% +$40.2K 0.13% 143
2013
Q2 		$3.45M Buy
+83,233
New +$3.64M 0.12% 151

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ABBV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its AbbVie (ABBV) stake by 7.2% in Q4 2019, buying an estimated $2.01M and bringing the position to 360,025 shares worth $30.9M. The position accounts for 0.19% of the portfolio, ranked #117.

Ladenburg Thalmann Financial Services first reported a position in ABBV in Q2 2013 and has held it in 27 quarters since. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 360,025 shares of AbbVie worth $30.9M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 24,193 AbbVie shares in Q4 2019, an estimated $2.01M.
  • AbbVie made up 0.19% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #117 holding.
  • Ladenburg Thalmann Financial Services first reported a position in AbbVie in Q2 2013 and has held it in 27 quarters since.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.